Daniel Karlin
CIK 1897618 · Chief Medical Officer · last filed 2026-03-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$10.23M
Companies
2
Total Filings
29
Lifetime Open-Market Net
-$755.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DFTX | Chief Medical Officer | 413,317 | $24.75 | $10.23M | -$148.1K | 2 | 2026-03-26 |
| Definium Therapeutics, Inc. (MNMD) Delisted | Chief Medical Officer | 425,025 | $15.00 | $6.38M | -$607.6K | 27 | 2025-12-29 |
Recent Filings · Page 3 of 3
29 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-09-01 | Definium Therapeutics, Inc. (MNMD) Delisted | Sell (S) | −1,204 | -$14.1K | EDGAR |
| 2022-07-27 | Definium Therapeutics, Inc. (MNMD) Delisted | Sell (S) | −18,217 | -$12.6K | EDGAR |
| 2022-06-28 | Definium Therapeutics, Inc. (MNMD) Delisted | Sell (S) | −26,238 | -$18.4K | EDGAR |
| 2022-05-31 | Definium Therapeutics, Inc. (MNMD) Delisted | Sell (S) | −9,555 | -$7.8K | EDGAR |
| 2022-05-26 | Definium Therapeutics, Inc. (MNMD) Delisted | Sell (S) | −8,242 | -$6.3K | EDGAR |
| 2022-04-27 | Definium Therapeutics, Inc. (MNMD) Delisted | Tax (F) | −13,038 | -$10.6K | EDGAR |
| 2022-03-29 | Definium Therapeutics, Inc. (MNMD) Delisted | Tax (F) | −10,203 | -$11.9K | EDGAR |
| 2022-03-28 | Definium Therapeutics, Inc. (MNMD) Delisted | Grant (A) | +950,000 | $0 | EDGAR |
| 2022-03-01 | Definium Therapeutics, Inc. (MNMD) Delisted | Tax (F) | −118,143 | -$143.0K | EDGAR |
Showing 21–29 of 29
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.